Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Endometrial Neoplasms × Bevacizumab × Clear all

Phase

Status

Recruiting 11 Completed 6 Not yet recruiting 2 Active not recruiting 2 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 47 Carcinoma, Non-Small-Cell Lung 20 Breast Neoplasms 14 Ovarian Neoplasms 13 Rectal Neoplasms 12 Neoplasm Metastasis 9 Glioblastoma 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Uterine Cervical Neoplasms 6 Carcinoma, Renal Cell 6 Fallopian Tube Neoplasms 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 3 Recurrence 3 Pleural Effusion, Malignant 3 Nasopharyngeal Carcinoma 3 Melanoma 3 Lung Neoplasms 3 Colorectal Cancer Metastatic 3 Non-squamous Non-small Cell Lung Cancer 2 Non-small Cell Lung Cancer Metastatic 2 Neoplasms 2 Liver Neoplasms 2 Liver Metastasis Colon Cancer 2 Kidney Neoplasms 2 Intestinal Neoplasms 2 Inflammatory Breast Neoplasms 2 Glioma 2

Interventions

Paclitaxel 6 Radiotherapy 5 Carboplatin 5 olaparib 4 Cisplatin 4 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Metformin 3 lenvatinib 2 durvalumab 2 dostarlimab 2 anlotinib 2 Sentinel Lymph Node Biopsy 2 Reverse Transcriptase Polymerase Chain Reaction 2 Progesterone 2 Magnetic Resonance Spectroscopy 2 Hematologic Tests 2 Genetic Testing 2 Blood Specimen Collection 2 Amplified Fragment Length Polymorphism Analysis 2 vistusertib 1 serabelisib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 onapristone 1 niraparib 1 liposomal doxorubicin 1 ixabepilone 1 gallium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01770171 2013-01-17

MITOBEVAEND2

Catholic University of the Sacred Heart

Phase 2 Unknown

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡